Pradaxa® is a simple treatment option that is as effective as warfarin with significantly lower bleeding rates, a major advance for DVT and PE patients 1–4 EU approval follows recent U.S. FDA approval ...

The FDA announced today that it was initiating a safety review of dabigatran (Pradaxa, Boehringer Ingelheim). The review was prompted by reports of serious bleeding events in people taking the drug.

Dallas, Nov 18 (Reuters) - An experimental antidote to the widely used blood clot preventer Pradaxa worked immediately and completely in an early-stage trial among healthy volunteers, raising hopes ...

Pradaxa is under fire again. Should drug company executives who are responsible for turning a drug into a financial winner also have a say over how a drug's risks are communicated to doctors and ...

The most effective journal ads of 2011 included those for Humira, Pradaxa and Conceptus’ Essure Procedure, according to the Doctors’ Choice Study. For the study, meant to show the value of print ...

Boehringer Ingelheim's Pradaxa blood clot preventer has been associated with a slightly higher risk of heart attack or acute coronary syndrome, according to results of a meta-analysis of several ...

The death of an elderly man from a massive brain hemorrhage after a routine fall suggests that bleeding complications from Boehringer Ingelheim's Pradaxa blood clot preventer are largely irreversible, ...

Abstract sphere from a blood clot cells background. Scientific and medical microbiological concept. Enrichment with oxygen and important nutrients. Transfer of important elements, 3d illustration ...

Patients taking the new anti-clotting drug Pradaxa have a 33% higher risk of heart attack or severe symptoms of heart disease than do patients taking warfarin. The finding, from Cleveland Clinic ...

Patients with a faulty heartbeat want Pradaxa - and their clinicians want them to have it, too. You can understand why - when the UK authorities licensed the drug for treating atrial fibrillation in ...